Clinical Efficacy, Cost-effectiveness and Mechanistic Evaluation of aflibercept for Proliferative Diabetic Retinopathy (acronym CLARITY): a noninferiority randomised trial
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
NIHR Efficacy and Mechanistic Evaluation (EME) Programme Report
| Iaith wreiddiol | Saesneg |
|---|---|
| Cyhoeddwr | NIHR |
| Statws | Cyhoeddwyd - Ion 2018 |